Cost-effectiveness of artesunate for the treatment of severe malaria.

Cost-effectiveness of artesunate for the treatment of severe malaria.

OBJECTIVE: To explore the cost-effectiveness of artesunate against quinine based principally on the findings of a large multi-centre trial carried out in Southeast Asia. METHODS: Trial data were used to compare mortality of patients with severe malaria, treated with either artesunate or quinine. Th...

Bibliografske podrobnosti
Main Authors:	Lubell, Y, Yeung, S, Dondorp, A, Day, N, Nosten, F, Tjitra, E, Abul Faiz, M, Yunus, E, Anstey, N, Mishra, S, Mohanty, S, White, N, Mills, A
Format:	Journal article
Jezik:	English
Izdano:	2009

Podobne knjige/članki

Artesunate versus quinine for severe falciparum malaria - Reply
od: White, N, et al.
Izdano: (2006)

Artesunate dosing in severe falciparum malaria.
od: Dondorp, A, et al.
Izdano: (2012)

Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial.
od: Dondorp, A, et al.
Izdano: (2005)

Artesunate for severe malaria in African children Reply
od: Dondorp, A, et al.
Izdano: (2011)

Cost-effectiveness of parenteral artesunate for treating children with severe malaria in sub-Saharan Africa.
od: Lubell, Y, et al.
Izdano: (2011)

The relationship between age and the manifestations of and mortality associated with severe malaria.
od: Dondorp, A, et al.
Izdano: (2008)

The relationship between age and the manifestations of and mortality associated with severe malaria
od: Dondorp, A, et al.
Izdano: (2008)

Artesunate for severe malaria in African children - Authors' reply
od: Dondorp, A, et al.
Izdano: (2011)

Improving the availability of artesunate for treatment of severe malaria.
od: Anstey, N, et al.
Izdano: (2006)

Does artesunate prolong the electrocardiograph QT interval in patients with severe malaria?
od: Maude, R, et al.
Izdano: (2009)

Cost-effectiveness of parenteral artesunate for treating children with severe malaria in sub-saharan Africa
od: Lubell, Y, et al.
Izdano: (2011)

Cost-effectiveness of parenteral artesunate for treating children with severe malaria in sub-Saharan Africa
od: Yoel Lubell, et al.
Izdano: (2011-07-01)

A simple score to predict the outcome of severe malaria in adults.
od: Hanson, J, et al.
Izdano: (2010)

UK recommendations for severe malaria are worrying.
od: White, N, et al.
Izdano: (2007)

Randomized comparison of artesunate and quinine in the treatment of severe falciparum malaria.
od: Newton, P, et al.
Izdano: (2003)

RECTAL AND INTRAVENOUS ARTESUNATE FOR SEVERE MALARIA: MODELLING THE IMPACT OF ARTEMISININ RESISTANCE
od: Maude, R, et al.
Izdano: (2010)

Rapid clinical assessment to facilitate the triage of adults with falciparum malaria, a retrospective analysis.
od: Hanson, J, et al.
Izdano: (2014)

Oral artesunate in the treatment of uncomplicated hyperparasitemic falciparum malaria.
od: Luxemburger, C, et al.
Izdano: (1995)

HYPOTHESES OF DRUG RESPONSE DYNAMICS TO EXPLAIN RECRUDESCENCE IN ARTESUNATE RESISTANT PLASMODIUM FALCIPARUM MALARIA
od: Maude, R, et al.
Izdano: (2009)

Population pharmacokinetics of intramuscular artesunate in african children with severe malaria: Implications for a practical dosing regimen
od: Hendriksen, I, et al.
Izdano: (2013)

Population pharmacokinetics of intramuscular artesunate in African children with severe malaria: implications for a practical dosing regimen.
od: Hendriksen, I, et al.
Izdano: (2013)

A randomized comparison of dihydroartemisinin-piperaquine and artesunate-amodiaquine combined with primaquine for radical treatment of vivax malaria in Sumatera, Indonesia.
od: Pasaribu, A, et al.
Izdano: (2013)

Pharmacokinetics of oral artesunate in children with moderately severe Plasmodium falciparum malaria.
od: Bethell, D, et al.
Izdano: (1997)

Randomized controlled trial of artesunate or artemether in Vietnamese adults with severe falciparum malaria.
od: Phu, N, et al.
Izdano: (2010)

The pharmacokinetics of intravenous artesunate in adults with severe falciparum malaria.
od: Newton, P, et al.
Izdano: (2006)

Vivax malaria: neglected and not benign.
od: Price, R, et al.
Izdano: (2007)

Vivax malaria: neglected and not benign.
od: Price, R, et al.
Izdano: (2007)

Comparison of artemisinin suppositories, intramuscular artesunate and intravenous quinine for the treatment of severe childhood malaria.
od: Cao, X, et al.
Izdano: (1997)

An artesunate pharmacometric model to explain therapeutic responses in falciparum malaria.
od: Saralamba, S, et al.
Izdano: (2023)

Pyronaridine-artesunate for uncomplicated falciparum malaria.
od: Nosten, F
Izdano: (2010)

WHO should accelerate, not stall, rectal artesunate deployment for pre-referral treatment of severe malaria
od: Peto, TJ, et al.
Izdano: (2023)

Severe allergic reactions to oral artesunate: a report of two cases.
od: Leonardi, E, et al.
Izdano: (2001)

The treatment of severe malaria.
od: Dondorp, A, et al.
Izdano: (2007)

Two patients with falciparum malaria and poor in vivo responses to artesunate.
od: Luxemburger, C, et al.
Izdano: (1998)

Treating severe malaria with pre-referral artesunate saves lives and prevents CNS damage
od: Gomes, M, et al.
Izdano: (2009)

Artesunate/mefloquine treatment of multi-drug resistant falciparum malaria.
od: Price, R, et al.
Izdano: (1997)

Severe Malaria and Artesunate Treatment, Norway
od: Kristine Mørch, et al.
Izdano: (2008-11-01)

Opposite malaria and pregnancy effect on oral bioavailability of artesunate - a population pharmacokinetic evaluation.
od: Kloprogge, F, et al.
Izdano: (2015)

Artesunate versus artemether in combination with mefloquine for the treatment of multidrug-resistant falciparum malaria.
od: Price, R, et al.
Izdano: (1995)

Comparative pharmacokinetics of intramuscular artesunate and artemether in patients with severe falciparum malaria.
od: Hien, T, et al.
Izdano: (2004)